These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7370545)

  • 1. Depot medroxyprogesterone and vaginal bleeding in the puerperium.
    Thiery M; Staelens R; Sanctorum C; Cliquet RL
    Br Med J; 1980 Feb; 280(6212):481-2. PubMed ID: 7370545
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of depot medroxyprogesterone acetate on vaginal bleeding in the puerperium.
    Murphy HM
    Br Med J; 1979 Dec; 2(6202):1400-1. PubMed ID: 519479
    [No Abstract]   [Full Text] [Related]  

  • 3. Injectable long-acting progestogen contraception: a neglected modality.
    Rosenfield AG
    Am J Obstet Gynecol; 1974 Oct; 120(4):537-48. PubMed ID: 4606673
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed postpartum sterilization.
    Mowat J
    Br Med J; 1974 May; 2(5914):306-8. PubMed ID: 4275062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of depot medroxyprogesterone acetate-related vaginal bleeding improves continuation rates in adolescents.
    Rager KM; Fowler A; Omar HA
    ScientificWorldJournal; 2006 Mar; 6():353-5. PubMed ID: 16547584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Parenteral contraceptive drugs: depot progestins].
    Rabe T; Runnebaum B
    Wien Med Wochenschr; 1987 Nov; 137(20-21):474-9. PubMed ID: 2967589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the clinical use of depomedroxyprogesterone acetate as an antiovulatory and ovariostatic agent, especially in lactating puerperas].
    Mengaldo R
    Minerva Ginecol; 1974 Jun; 26(6):358-66. PubMed ID: 4858750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of Depo Provera as a contraceptive in the puerperium].
    Narducci U; Piatti N
    Minerva Ginecol; 1973 Feb; 25(2):107-11. PubMed ID: 4735312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depot medroxyprogesterone acetate (Depo-Provera) as a contraceptive preparation.
    Bloch B
    S Afr Med J; 1971 Jul; 45(28):777-80. PubMed ID: 5106836
    [No Abstract]   [Full Text] [Related]  

  • 10. PROLONGED POSTPARTUM DYSFUNCTIONAL UTERINE BLEEDING SUBSEQUENT TO PRENATAL THERAPY WITH PARENTERAL POTENT PROGESTOGENS.
    TURNER SJ
    Obstet Gynecol; 1964 Aug; 24():218-21. PubMed ID: 14199528
    [No Abstract]   [Full Text] [Related]  

  • 11. Dysfunctional bleeding subsequent to progestin therapy.
    Luby RJ
    Obstet Gynecol; 1965 Oct; 26(4):467-9. PubMed ID: 5294149
    [No Abstract]   [Full Text] [Related]  

  • 12. Medroxyprogesterone acetate as a contraceptive for female drug addicts.
    Mark I
    Scand J Soc Med; 1983; 11(3):75-80. PubMed ID: 6230717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depot medroxyprogesterone and risk of breast cancer.
    Gray RH
    BMJ; 1989 Oct; 299(6707):1099. PubMed ID: 2531619
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experiences with laparoscopic tubal sterilization in the puerperium].
    Haag B; Bogdan C; Hinselmann M
    Gynakol Rundsch; 1974; 14(4):323-4. PubMed ID: 4280373
    [No Abstract]   [Full Text] [Related]  

  • 15. Depot medroxyprogesterone acetate for contraception: a continuing controversy.
    Int J Gynaecol Obstet; 1979; 16(5):433-41. PubMed ID: 35417
    [No Abstract]   [Full Text] [Related]  

  • 16. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
    Rosenfield A; Maine D; Rochat R; Shelton J; Hatcher RA
    JAMA; 1983 Jun; 249(21):2922-8. PubMed ID: 6221125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Depot medroxyprogesterone acetate as contraceptive agent].
    Duarte-Contreras A
    Rev Colomb Obstet Ginecol; 1973; 24(1):13-9. PubMed ID: 4804874
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medroxyprogesterone in the postpartum. Single dose administration].
    Ruíz-Velasco V; García Jión LF; Mejía Restrepo J; Arzate Delgado M
    Ginecol Obstet Mex; 1979 Mar; 45(269):199-206. PubMed ID: 396168
    [No Abstract]   [Full Text] [Related]  

  • 19. Galactorrhea in DMPA users: incidence and clinical significance.
    Gongsakdi D; Rojanasakul A
    J Med Assoc Thai; 1986 Jan; 69(1):28-32. PubMed ID: 2937870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Late post-partum or post-abortum metrorrhagia in patients administered delayed-action hydroxyprogesterone caproate during pregnancy (apropos of 5 cases)].
    Gaujoux J; Djian R; Béchet YM
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(3):315-7. PubMed ID: 5479056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.